Oscar Health, Inc. (OSCR)
Oscar Health, Inc. (OSCR) is a healthcare company (healthcare plans) based in the United States. The share price is $30.69, down 2.04% on the day, which values the company at $9.53B. Price as of 17 Nov 2026, 18:23 UTC, from Yahoo Finance.
Key facts
- Share price
- $30.69−2.04% today
- Market value
- $9.53B
- P/E ratio
- 13.6×last 12 months
- Forward P/E
- 12.5×
- Funk Score
- 62/100
- Against its own history
- Well above its usual priceusual price $14.37
- 200-week average
- $15.6197% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Oscar Health, Inc. in more detail
OSCR trades at 13.6× its last twelve months' earnings, 12.5× next year's expected earnings, 0.5× sales. Measured against its own history, the price is 114% above what its usual multiples would imply ($14.37) — well above its usual price. It sits 97% above its 200-week average of $15.61.
Over the last five fiscal years Oscar Health, Inc. has compounded free cash flow 38.4% a year. Its Funk Score is 62 out of 100 (financial strength 7.1, profitability 2.8, growth 10.0, value 5.0, each out of 10).
In its favour: More cash than debt. Worth checking: Weak Piotroski score.
3 of the superinvestors tracked here hold OSCR, including David Shaw (founder) (0.2% of the portfolio), Jim Simons (1938–2024) (0.2% of the portfolio), Polen Capital team (0.1% of the portfolio).
Superinvestors holding OSCR
3 of the investors tracked here report a position in their latest 13F filing.
- David Shaw (founder) D. E. Shaw & Co.0.22% of portfolio · $360.6M · added · Q2 2026
- Jim Simons (1938–2024) Renaissance Technologies0.16% of portfolio · $118.7M · added · Q3 2026
- Polen Capital team Polen Capital Management0.06% of portfolio · $5.1M · added · Q3 2026
Health Care companies of similar size
- Spyre TherapeuticsSYRE
- QiagenQGEN
- InsuletPODD
- BrukerBRKR
- Globus MedicalGMED
- Madrigal PharmaceuticalsMDGL
- Henry ScheinHSIC
- TG TherapeuticsTGTX
- Praxis Precision MedicinesPRAX
- Twist BioscienceTWST
- Protagonist TherapeuticsPTGX
- Krystal BiotechKRYS
Side by side:OSCR vs HSIC (Oscar Health, Inc. vs Henry Schein)OSCR vs TGTX (Oscar Health, Inc. vs TG Therapeutics)OSCR vs MDGL (Oscar Health, Inc. vs Madrigal Pharmaceuticals)OSCR vs GMED (Oscar Health, Inc. vs Globus Medical)OSCR vs PRAX (Oscar Health, Inc. vs Praxis Precision Medicines)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Oscar Health, Inc. (OSCR): questions and answers
What is OSCR's P/E ratio?
Oscar Health, Inc. trades at 13.6× its last twelve months' earnings and 12.5× next year's expected earnings.
What is Oscar Health, Inc.'s market cap?
Oscar Health, Inc. is valued at $9.53B at a share price of $30.69.
Is OSCR overvalued or undervalued?
Against its own history, OSCR is well above its usual price: the price is 114% above the $14.37 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is OSCR above its 200-week moving average?
Yes. OSCR is 96.6% above its 200-week average of $15.61. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Oscar Health, Inc. growing?
Over the last three fiscal years Oscar Health, Inc.'s revenue grew 41.6% a year.
Does OSCR pay a dividend?
Oscar Health, Inc. does not currently pay a regular dividend.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Oscar Health, Inc. (OSCR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/OSCR
Underlying data: Yahoo Finance; company filings with the SEC.